Guardant Health Inc. (GH) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3100 HANOVER STREET PALO ALTO, CA 94304 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 1,177,234 | 1,036,231 | 972,148 | 1,794,880 | 522,802 | 418,961 | |||
| Cash and cash equivalents | 1,133,537 | 141,647 | 492,202 | 832,977 | 143,228 | 140,544 | |||
| Short-term investments | 43,697 | 894,584 | 479,946 | 961,903 | 379,574 | 278,417 | |||
| Receivables | 88,783 | 97,256 | 97,652 | 53,299 | 47,986 | 35,690 | |||
| Inventory, net of allowances, customer advances and progress billings | 61,948 | 51,598 | 30,674 | 22,716 | 15,181 | 9,136 | |||
| Inventory | 61,948 | 51,598 | 30,674 | 22,716 | 15,181 | 9,136 | |||
| Other undisclosed current assets | 19,141 | 6,509 | 13,652 | 17,466 | 11,389 | 5,204 | |||
| Total current assets: | 1,347,106 | 1,191,594 | 1,114,126 | 1,888,361 | 597,358 | 468,991 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 157,616 | 174,001 | 189,443 | 37,343 | ✕ | ||||
| Property, plant and equipment | 145,096 | 167,920 | 124,461 | 62,782 | 43,668 | 31,003 | |||
| Long-term investments and receivables | 698,034 | 246,597 | 268,783 | 77,563 | |||||
| Long-term investments | 698,034 | 246,597 | 268,783 | 77,563 | |||||
| Intangible assets, net (including goodwill) | 12,269 | 15,017 | 17,497 | 19,445 | 11,814 | ||||
| Goodwill | 3,290 | 3,290 | 3,290 | 3,290 | 3,290 | ||||
| Intangible assets, net (excluding goodwill) | 8,979 | 11,727 | 14,207 | 16,155 | 8,524 | ||||
| Other noncurrent assets | 124,334 | 61,453 | 60,938 | 17,208 | 4,882 | 2,046 | |||
| Other undisclosed noncurrent assets | 45 | 36,030 | 7,800 | ||||||
| Total noncurrent assets: | 439,315 | 418,391 | 1,090,373 | 383,420 | 365,177 | 118,412 | |||
| TOTAL ASSETS: | 1,786,421 | 1,609,985 | 2,204,499 | 2,271,781 | 962,535 | 587,403 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 187,952 | 175,817 | 62,865 | 29,979 | 41,900 | 17,723 | |||
| Accounts payable | 68,911 | 17,580 | 7,340 | 16,197 | 10,642 | ||||
| Accrued liabilities | 187,952 | 85,028 | 45,285 | 22,639 | 25,703 | 7,081 | |||
| Other undisclosed accounts payable and accrued liabilities | 21,878 | ||||||||
| Deferred revenue | 17,965 | 17,403 | 11,326 | 8,550 | ✕ | ||||
| Debt | 97 | ||||||||
| Deferred compensation liability | 42,496 | 28,280 | 18,557 | 12,986 | |||||
| Other undisclosed current liabilities | 78,000 | 12,277 | 16,138 | ||||||
| Total current liabilities: | 205,917 | 193,220 | 194,687 | 66,809 | 72,734 | 46,944 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 1,139,966 | 1,137,391 | 1,360,874 | 847,857 | 119 | ||||
| Long-term debt, excluding current maturities | 1,139,966 | 1,137,391 | 1,134,821 | 806,292 | |||||
| Capital lease obligations | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 119 | ||
| Liabilities, other than long-term debt | 281,854 | 219,194 | 3,933 | 1,520 | 1,772 | 8,050 | |||
| Deferred compensation liability, classified | 100 | ||||||||
| Deferred rent credit | 7,844 | ||||||||
| Other liabilities | 96,006 | 9,179 | 3,933 | 1,520 | 1,672 | 206 | |||
| Operating lease, liability | 185,848 | 210,015 | 226,053 | 41,565 | ✕ | ||||
| Other undisclosed noncurrent liabilities | 40,036 | 7,338 | |||||||
| Total noncurrent liabilities: | 1,421,820 | 1,356,585 | 1,364,807 | 849,377 | 41,808 | 15,507 | |||
| Total liabilities: | 1,627,737 | 1,549,805 | 1,559,494 | 916,186 | 114,542 | 62,451 | |||
| Temporary equity, carrying amount | 57,100 | 49,600 | 41,800 | ||||||
| Equity | |||||||||
| Equity, attributable to parent, including: | 158,684 | 60,180 | 645,005 | 1,298,495 | 798,393 | 483,152 | |||
| Additional paid in capital | 2,304,220 | 1,742,114 | 1,657,593 | 1,902,389 | 1,150,090 | 764,033 | |||
| Accumulated other comprehensive income (loss) | (3,675) | (19,522) | (4,764) | 2,697 | 1,111 | (83) | |||
| Accumulated deficit | (2,141,862) | (1,662,413) | (1,007,825) | (606,592) | (352,809) | (280,799) | |||
| Other undisclosed equity, attributable to parent | 1 | 1 | 1 | 1 | 1 | 1 | |||
| Total equity: | 158,684 | 60,180 | 645,005 | 1,298,495 | 798,393 | 483,152 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,786,421 | 1,609,985 | 2,204,499 | 2,271,781 | 962,535 | 587,403 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 563,948 | 449,538 | 373,653 | 286,730 | 214,375 | 90,639 | ||
| Cost of revenue | (224,352) | (153,125) | (120,312) | (89,635) | (66,320) | (41,646) | ||
| Gross profit: | 339,596 | 296,413 | 253,341 | 197,095 | 148,055 | 48,993 | ||
| Operating expenses | (904,321) | (840,791) | (664,342) | (452,045) | (230,426) | (141,935) | ||
| Operating loss: | (564,725) | (544,378) | (411,001) | (254,950) | (82,371) | (92,942) | ||
| Nonoperating income (expense) | 88,539 | (6,709) | 29,108 | 13,812 | 13,829 | 9,968 | ||
| Investment income, nonoperating | 35,365 | 6,069 | 3,930 | 10,171 | 13,741 | 5,266 | ||
| Other nonoperating income (expense) | 53,174 | (12,778) | 25,178 | 3,641 | 88 | 4,702 | ||
| Interest and debt expense | (2,578) | (2,577) | (2,577) | (4,766) | (1,181) | (1,251) | ||
| Loss from continuing operations before equity method investments, income taxes: | (478,764) | (553,664) | (384,470) | (245,904) | (69,723) | (84,225) | ||
| Other undisclosed loss from continuing operations before income taxes | (99,785) | |||||||
| Loss from continuing operations before income taxes: | (478,764) | (653,449) | (384,470) | (245,904) | (69,723) | (84,225) | ||
| Income tax expense (benefit) | (685) | (1,139) | (300) | (379) | 1,872 | (38) | ||
| Loss from continuing operations: | (479,449) | (654,588) | (384,770) | (246,283) | (67,851) | (84,263) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (384,770) | (246,283) | (67,851) | (84,263) | |
| Net loss: | (479,449) | (654,588) | (384,770) | (246,283) | (67,851) | (84,263) | ||
| Net loss attributable to noncontrolling interest | (20,900) | (7,500) | (7,800) | (800) | ||||
| Net loss attributable to parent: | (479,449) | (654,588) | (405,670) | (253,783) | (75,651) | (85,063) | ||
| Preferred stock dividends and other adjustments | (1,100) | (1,100) | ||||||
| Other undisclosed net income available to common stockholders, basic | 1,100 | 1,100 | ||||||
| Net loss available to common stockholders, diluted: | (479,449) | (654,588) | (405,670) | (253,783) | (75,651) | (85,063) | ||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (479,449) | (654,588) | (384,770) | (246,283) | (67,851) | (84,263) | ||
| Other comprehensive income (loss) | 15,847 | (14,758) | (7,461) | 1,586 | 1,194 | 449 | ||
| Comprehensive loss: | (463,602) | (669,346) | (392,231) | (244,697) | (66,657) | (83,814) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (20,900) | (7,500) | (7,800) | (800) | ||||
| Comprehensive loss, net of tax, attributable to parent: | (463,602) | (669,346) | (413,131) | (252,197) | (74,457) | (84,614) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.